This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Designing an IHC experiment for SPTBN2? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the SPTBN2 IHC GuideFacts about Spectrin beta chain, non-erythrocytic 2.
| Human | |
|---|---|
| Gene Name: | SPTBN2 |
| Uniprot: | O15020 |
| Entrez: | 6712 |

| Belongs to: |
|---|
| spectrin family |

beta-III Spectrin; glutamate transporter EAAT4-associated protein 41; GTRAP41; KIAA0302; SCA5; SCAR14; Spectrin beta 3; spectrin beta chain, brain 2; Spectrin beta III; spectrin, beta, non-erythrocytic 2; Spectrin, non-erythroid beta chain 2; spinocerebellar ataxia 5; SPTBN2
Mass (kDA):
271.325 kDA

| Human | |
|---|---|
| Location: | 11q13.2 |
| Sequence: | 11; NC_000011.10 (66682496..66729361, complement) |
Highly expressed in brain, kidney, pancreas, and liver, and at lower levels in lung and placenta.
Cytoplasm, cytoskeleton. Cytoplasm, cell cortex.




PMID: 9826670 by Stankewich M.C., et al. A widely expressed betaIII spectrin associated with Golgi and cytoplasmic vesicles.
PMID: 23236289 by Lise S., et al. Recessive mutations in SPTBN2 implicate beta-III spectrin in both cognitive and motor development.